UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041103
Receipt number R000046767
Scientific Title Data collection and clinical epidemiological evaluation based on the construction and management of a registry of ulcerative colitis (UC)
Date of disclosure of the study information 2020/07/14
Last modified on 2022/07/19 10:21:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Data collection and clinical epidemiological evaluation based on the construction and management of a registry of ulcerative colitis (UC)

Acronym

Data collection and clinical epidemiological evaluation based on the construction and management of a registry of ulcerative colitis (UC)

Scientific Title

Data collection and clinical epidemiological evaluation based on the construction and management of a registry of ulcerative colitis (UC)

Scientific Title:Acronym

Data collection and clinical epidemiological evaluation based on the construction and management of a registry of ulcerative colitis (UC)

Region

Japan


Condition

Condition

ulcerative colitis (UC)

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To construct the registry of patients with UC in Japan and observe the treatment pattern, course of disease, and adverse events

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

N/A
Because the purpose of this study is construct registry.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients who were 18 years-old or more at the time of informed consent in this study
2. Patients who diagnosed UC based on UC diagnostic criteria according to the treatment guidelines "Research on Intractable Inflammatory Bowel Disease" at the time of informed consent in this study
3. Patients who obtained written informed consent

Key exclusion criteria

Patients who were deemed unsuitable for inclusion in this study by investigators

Target sample size

5000


Research contact person

Name of lead principal investigator

1st name Katsuyoshi
Middle name
Last name Matsuoka

Organization

Toho University Sakura Medical Center

Division name

Division of Gastroenterology and Hepatology, Department of Internal Medicine

Zip code

285-8741

Address

564-1 Shimoshizu, Sakura, Chiba, Japan

TEL

043-462-8811

Email

matsuoka@fk2.so-net.ne.jp


Public contact

Name of contact person

1st name Iwanaga
Middle name
Last name Yusuke

Organization

Mebix, Inc.

Division name

Division of research promotion

Zip code

541-0046

Address

9F. Aioi Nissay Dowa Insurance Midosuji Building, 3-6-1 Hirano-cho, Chuo-ku, Osaka-shi, Osaka, Japan

TEL

06-6226-0657

Homepage URL


Email

yusuke.iwanaga@mebix.co.jp


Sponsor or person

Institute

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University Sakura Medical Center

Institute

Department

Personal name



Funding Source

Organization

Mebix, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Toho University Sakura Medical Center

Address

564-1 Shimoshizu, Sakura, Chiba, Japan

Tel

043-462-8811

Email

sakura.rinri@ext.toho-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北里大学北里研究所病院(東京都)、東京医科歯科大学医学部附属病院(東京都)、旭川医科大学病院(北海道)、九州大学病院(福岡県)、滋賀医科大学医学部附属病院(滋賀県)


Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 08 Month 14 Day

Date of IRB

2020 Year 02 Month 06 Day

Anticipated trial start date

2021 Year 11 Month 22 Day

Last follow-up date

2023 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is a observational study.


Management information

Registered date

2020 Year 07 Month 14 Day

Last modified on

2022 Year 07 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046767


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name